MiltonDavidGrossMD
Nuclear Medicine • Ann Arbor, MIProfessor Emeritus Department of Radiology University of Michigan
Dr. Gross is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 East Medical Center Dr
B1 Floor University Hospital Room B1g412
Ann Arbor, MI 48109Phone+1 734-936-5388
Summary
- Dr. Milton Gross is a Nuclear Medicine specialist based in Ann Arbor, MI. He completed his medical education, residency in Internal Medicine, and fellowships in Nuclear Medicine and Endocrinology, Diabetes, and Metabolism at the University of Michigan. After retiring from the VA in 2019, he has served as a Professor Emeritus at the University of Michigan Medical Center. Dr. Gross has a number of notable publications, including works on the impact of infection and inflammation on oncologic imaging, the effects of plasma glucose on brain PET imaging for dementia evaluation, and therapies for prostate carcinoma and Graves' hyperthyroidism. His research contributions have been referenced by other publications multiple times.
Education & Training
- University of MichiganFellowship, Endocrinology, Diabetes, and Metabolism, 1977 - 1980
- University of MichiganResidency, Internal Medicine, 1974 - 1977
- University of Michigan Medical SchoolClass of 1974
Certifications & Licensure
MI State Medical License 1975 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Nuclear Medicine Nuclear Medicine
Publications & Presentations
PubMed
- 80 citationsThe impact of infection and inflammation in oncologic 18F-FDG PET/CT imagingW. Tania Rahman, Daniel J. Wale, Benjamin L. Viglianti, Danyelle M. Townsend, Matthew S. Manganaro
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 2019-09-01 - 22 citationsGreater reduction in mid-treatment FDG-PET volume may be associated with worse survival in non-small cell lung cancer.Feng-Ming Spring Kong, Ling Li, Weili Wang, J. Campbell, Jennifer L. Waller
Radiotherapy and Oncology. 2019-03-01 - 8 citationsEffects of plasma glucose levels on regional cerebral 18F-fluorodeoxyglucose uptake: Implications for dementia evaluation with brain PET imaging.Benjamin L. Viglianti, Daniel J. Wale, Tianwen Ma, Timothy D. Johnson, Nicolaas I. Bohnen
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 2019-02-20
Press Mentions
Long-Term Changes in Behavior and Regional Cerebral Blood Flow Associated with Painful Peripheral Mononeuropathy in the RatMarch 15th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
